628 results
Page 2 of 32
8-K
9mqmd
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
ob3v qlaiz3logfsx
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
2m4d8nkthjjen3q19
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
mhyq6u2jas9
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
fud9kud
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.1
mzf s2z73
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
vwfdvasdampqhiy89m
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
fodn 7bxkhqe
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
5q0nng22iaq8w1c0q12a
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
ftloc8wd
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
u0x83q4sy l8rafm
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
s2joarc73on1cnb
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
kr4trtze6s5hswdix
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
7qy7htoid4nd nsza1g
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
5cjhfd5197ia91xfn
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
nz3 81yn3aolill
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
g9wbnq28s e255lziu
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
z4ge511laufn83s 7y
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
gx0 2ejqspptpy
10 Oct 23
Additional proxy materials by non-management
6:48am